Metabolic dysfunction, rather than obesity, is a risk factor for chronic kidney disease in Chinese population

References

• Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252. doi: 10.1016/S0140-6736(16)32064-5.
   PubMed Web of Science ®Google Scholar
• Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–733.
   PubMed Web of Science ®Google Scholar
• Hanna RM, Streja E, Kalantar-Zadeh K. Burden of anemia in chronic kidney disease: beyond erythropoietin. Adv Ther. 2021;38(1):52–75. doi: 10.1007/s12325-020-01524-6.
   PubMed Web of Science ®Google Scholar
• Batchelor EK, Kapitsinou P, Pergola PE, et al. Iron deficiency in chronic kidney disease: updates on pathophysiology, diagnosis, and treatment. J Am Soc Nephrol. 2020;31(3):456–468. doi: 10.1681/ASN.2019020213.
   PubMed Web of Science ®Google Scholar
• Pazianas M, Miller PD. Osteoporosis and chronic kidney disease-Mineral and bone disorder (CKD-MBD): back to basics. Am J Kidney Dis. 2021;78(4):582–589. doi: 10.1053/j.ajkd.2020.12.024.
   PubMed Web of Science ®Google Scholar
• Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–2081. doi: 10.1016/S0140-6736(10)60674-5.
   PubMed Web of Science ®Google Scholar
• Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA. 2006;296(23):2823–2831. doi: 10.1001/jama.296.23.2823.
   PubMed Web of Science ®Google Scholar
• Wong G, Hayen A, Chapman JR, et al. Association of CKD and cancer risk in older people. J Am Soc Nephrol. 2009;20(6):1341–1350. doi: 10.1681/ASN.2008090998.
   PubMed Web of Science ®Google Scholar
• Fraser SDS, Roderick PJ. Kidney disease in the global burden of disease study 2017. Nat Rev Nephrol. 2019;15(4):193–194. doi: 10.1038/s41581-019-0120-0.
   PubMed Web of Science ®Google Scholar
• Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21–28. doi: 10.7326/0003-4819-144-1-200601030-00006.
   PubMed Web of Science ®Google Scholar
• McMahon GM, Preis SR, Hwang SJ, et al. Mid-adulthood risk factor profiles for CKD. J Am Soc Nephrol. 2014;25(11):2633–2641. doi: 10.1681/ASN.2013070750.
   PubMed Web of Science ®Google Scholar
• Feng L, Chen T, Wang X, et al. Metabolism score for visceral fat (METS-VF): a new predictive surrogate for CKD risk. Diabetes Metab Syndr Obes. 2022;15:2249–2258. doi: 10.2147/DMSO.S370222.
   PubMedGoogle Scholar
• Lin L, Tan W, Pan X, et al. Metabolic syndrome-related kidney injury: a review and update. Front Endocrinol (Lausanne). 2022;13:904001. doi: 10.3389/fendo.2022.904001.
   PubMedGoogle Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415–1428. doi: 10.1016/S0140-6736(05)66378-7.
   PubMed Web of Science ®Google Scholar
• Yang S, Dai H, Hu W, et al. Association between circulating follistatin-like-1 and metabolic syndrome in Middle-aged and old population: a cross-sectional study. Diabetes Metab Res Rev. 2021;37(2):e3373.
   PubMed Web of Science ®Google Scholar
• Prasad GV. Metabolic syndrome and chronic kidney disease: current status and future directions. World J Nephrol. 2014;3(4):210–219. doi: 10.5527/wjn.v3.i4.210.
   PubMedGoogle Scholar
• Japar KV, Hariyanto TI, Mardjopranoto MS. Relationship between phenotype models based on waist circumference and triglyceride levels and the risk of chronic kidney disease: a systematic review and meta-analysis. J Obes Metab Syndr. 2023;32(3):236–246. doi: 10.7570/jomes23037.
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Abbasi F, Lamendola C, et al. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med. 2007;167(7):642–648. doi: 10.1001/archinte.167.7.642.
   PubMedGoogle Scholar
• Xiong Y, Zhang Y, Zhang F, et al. Prevalence and associated factors of metabolic syndrome in Chinese Middle-aged and elderly population: a national cross-sectional study. Aging Male. 2021;24(1):148–159. doi: 10.1080/13685538.2021.1998432.
   PubMed Web of Science ®Google Scholar
• Chang AR, Grams ME, Ballew SH, et al. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019;364:k5301. doi: 10.1136/bmj.k5301.
   PubMedGoogle Scholar
• Stefansson VTN, Schei J, Solbu MD, et al. Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population. Kidney Int. 2018;93(5):1183–1190. doi: 10.1016/j.kint.2017.11.012.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61–68. doi: 10.1093/ije/dys203.
   PubMed Web of Science ®Google Scholar
• Hou B, Nazroo J, Banks J, et al. Migration status and smoking behaviors in Later-Life in China-Evidence from the China health and retirement longitudinal study (CHARLS). Front Public Health. 2018;6:346. doi: 10.3389/fpubh.2018.00346.
   PubMed Web of Science ®Google Scholar
• Andresen EM, Byers K, Friary J, et al. Performance of the 10-item center for epidemiologic studies depression scale for caregiving research. SAGE Open Med. 2013;1:2050312113514576. doi: 10.1177/2050312113514576.
   Google Scholar
• Xiong Y, Zhang Y, Tan J, et al. The association between metabolic syndrome and lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males: evidence based on propensity score matching. Transl Androl Urol. 2021;10(1):384–396. doi: 10.21037/tau-20-1127.
   PubMed Web of Science ®Google Scholar
• Ye Z, Wu C, Xiong Y, et al. Obesity, metabolic dysfunction, and risk of kidney stone disease: a national cross-sectional study. Aging Male. 2023;26(1):2195932. doi: 10.1080/13685538.2023.2195932.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497. doi: 10.1001/jama.285.19.2486.
   PubMed Web of Science ®Google Scholar
• Takamiya T, Zaky WR, Edmundowics D, et al. World health organization-defined metabolic syndrome is a better predictor of coronary calcium than the adult treatment panel III criteria in American men aged 40-49 years. Diabetes Care. 2004;27(12):2977–2979. doi: 10.2337/diacare.27.12.2977.
   PubMed Web of Science ®Google Scholar
• Ford ES. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the US. Diabetes Care. 2005;28(11):2745–2749. doi: 10.2337/diacare.28.11.2745.
   PubMed Web of Science ®Google Scholar
• Luo H, Li J, Zhang Q, et al. Obesity and the onset of depressive symptoms among Middle-aged and older adults in China: evidence from the CHARLS. BMC Public Health. 2018;18(1):909. doi: 10.1186/s12889-018-5834-6.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhang YC, Jin T, et al. Depressive males have higher odds of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a retrospective cohort study based on propensity score matching. Asian J Androl. 2021;23(6):633–639. doi: 10.4103/aja.aja_12_21.
   PubMed Web of Science ®Google Scholar
• Hallan S, de Mutsert R, Carlsen S, et al. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis. 2006;47(3):396–405. doi: 10.1053/j.ajkd.2005.11.027.
   PubMed Web of Science ®Google Scholar
• Kelly JT, Su G, Zhang L, et al. Modifiable lifestyle factors for primary prevention of CKD: a systematic review and Meta-Analysis. J Am Soc Nephrol. 2021;32(1):239–253. doi: 10.1681/ASN.2020030384.
   PubMed Web of Science ®Google Scholar
• Park S, Lee S, Kim Y, et al. Short or long sleep duration and CKD: a mendelian randomization study. J Am Soc Nephrol. 2020;31(12):2937–2947. doi: 10.1681/ASN.2020050666.
   PubMed Web of Science ®Google Scholar
• Hundemer GL, Ravani P, Sood MM, et al. Social determinants of health and the transition from advanced chronic kidney disease to kidney failure. Nephrol Dial Transplant. 2023;38(7):1682–1690. doi: 10.1093/ndt/gfac302.
   PubMed Web of Science ®Google Scholar
• Liu M, Zhang Y, Yang S, et al. Bidirectional relations between depression symptoms and chronic kidney disease. J Affect Disord. 2022;311:224–230. doi: 10.1016/j.jad.2022.05.104.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L, Zhang W, et al. Understanding the relationship between circulating lipids and risk of chronic kidney disease: a prospective cohort study and large-scale genetic analyses. J Transl Med. 2023;21(1):671. doi: 10.1186/s12967-023-04509-5.
   PubMed Web of Science ®Google Scholar
• Garofalo C, Borrelli S, Minutolo R, et al. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017;91(5):1224–1235. doi: 10.1016/j.kint.2016.12.013.
   PubMed Web of Science ®Google Scholar
• Madero M, Katz R, Murphy R, et al. Comparison between different measures of body fat with kidney function decline and incident CKD. Clin J Am Soc Nephrol. 2017;12(6):893–903. doi: 10.2215/CJN.07010716.
   PubMed Web of Science ®Google Scholar
• Lucove J, Vupputuri S, Heiss G, et al. Metabolic syndrome and the development of CKD in American indians: the strong heart study. Am J Kidney Dis. 2008;51(1):21–28. doi: 10.1053/j.ajkd.2007.09.014.
   PubMed Web of Science ®Google Scholar
• Ming J, Xu S, Yang C, et al. Metabolic syndrome and chronic kidney disease in general chinese adults: results from the 2007-08 China national diabetes and metabolic disorders study. Clin Chim Acta. 2014;430:115–120. doi: 10.1016/j.cca.2014.01.004.
   PubMed Web of Science ®Google Scholar
• Lopes HF, Corrêa-Giannella ML, Consolim-Colombo FM, et al. Visceral adiposity syndrome. Diabetol Metab Syndr. 2016;8(1):40. doi: 10.1186/s13098-016-0156-2.
   PubMedGoogle Scholar
• Ramirez-Jimenez M, Morales-Palomo F, Moreno-Cabañas A, et al. Effects of antihypertensive medication and high-intensity interval training in hypertensive metabolic syndrome individuals. Scand J Med Sci Sports. 2021;31(7):1411–1419. doi: 10.1111/sms.13949.
   PubMed Web of Science ®Google Scholar
• Yang S, Cao C, Deng T, et al. Obesity-Related glomerulopathy: a latent change in obesity requiring more attention. Kidney Blood Press Res. 2020;45(4):510–522. doi: 10.1159/000507784.
   PubMed Web of Science ®Google Scholar
• Muñoz-Durango N, Fuentes CA, Castillo AE, et al. Role of the Renin-Angiotensin-Aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in End-Organ damage during arterial hypertension. Int J Mol Sci. 2016;17(7):797. doi: 10.3390/ijms17070797.
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Perico N, Macia M, et al. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl. 2005;68(99):S57–S65. doi: 10.1111/j.1523-1755.2005.09911.x.
   Google Scholar
• Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord. 2013;14(3):219–227. doi: 10.1007/s11154-013-9252-x.
   PubMed Web of Science ®Google Scholar
• Soriguer F, Gutiérrez-Repiso C, Rubio-Martín E, et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab. 2013;98(6):2318–2325. doi: 10.1210/jc.2012-4253.
   PubMed Web of Science ®Google Scholar
• Appleton SL, Seaborn CJ, Visvanathan R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8):2388–2394. doi: 10.2337/dc12-1971.
   PubMed Web of Science ®Google Scholar
• Hamer M, Bell JA, Sabia S, et al. Stability of metabolically healthy obesity over 8 years: the english longitudinal study of ageing. Eur J Endocrinol. 2015;173(5):703–708. doi: 10.1530/EJE-15-0449.
   PubMed Web of Science ®Google Scholar
• Cho YK, Lee J, Kim HS, et al. Impact of transition in metabolic health and obesity on the incident chronic kidney disease: a nationwide cohort study. J Clin Endocrinol Metab. 2020;105(3):dgaa033.
   PubMed Web of Science ®Google Scholar
• Ordovas JM, Corella D. Metabolic syndrome pathophysiology: the role of adipose tissue. Kidney Int Suppl. 2008;74(111):S10–S14. doi: 10.1038/ki.2008.517.
   Google Scholar
• Adair KE, von Waaden N, Rafalski M, et al. Metabolic phenotypes and chronic kidney disease: a Cross-Sectional assessment of patients from a large federally qualified health center. Life (Basel). 2021;11(2):175. doi: 10.3390/life11020175.
   PubMed Web of Science ®Google Scholar